-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Ursa Fund Management LLC Takes Position in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS)
Ursa Fund Management LLC Takes Position in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS)
Ursa Fund Management LLC acquired a new stake in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,000 shares of the company's stock, valued at approximately $243,000. Ursa Fund Management LLC owned about 0.10% of DA32 Life Science Tech Acquisition as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. Radcliffe Capital Management L.P. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at approximately $1,420,000. Saba Capital Management L.P. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at approximately $10,883,000. Fir Tree Capital Management LP acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter worth approximately $758,000. RP Investment Advisors LP lifted its holdings in DA32 Life Science Tech Acquisition by 653.1% during the 1st quarter. RP Investment Advisors LP now owns 408,856 shares of the company's stock worth $3,972,000 after purchasing an additional 354,569 shares during the last quarter. Finally, Verition Fund Management LLC acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter worth approximately $917,000. 60.43% of the stock is owned by institutional investors and hedge funds.
Get DA32 Life Science Tech Acquisition alerts:DA32 Life Science Tech Acquisition Price Performance
NASDAQ:DALS opened at $9.74 on Wednesday. The stock has a 50 day simple moving average of $9.72 and a 200 day simple moving average of $9.71. DA32 Life Science Tech Acquisition Corp. has a 1-year low of $9.58 and a 1-year high of $10.26.
About DA32 Life Science Tech Acquisition
(Get Rating)DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.
See Also
- Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
- Is Five Below Trying to Punch Too High?
- These 3 Reports Will Tell Us Much About the Current Economy
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating).
Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Ursa Fund Management LLC acquired a new stake in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,000 shares of the company's stock, valued at approximately $243,000. Ursa Fund Management LLC owned about 0.10% of DA32 Life Science Tech Acquisition as of its most recent SEC filing.
根据URSA基金管理公司向美国证券交易委员会(美国证券交易委员会)披露的最新信息,该公司在第一季度收购了DA32生命科学技术收购公司(DA32 Life Science Tech Acquisition Corp.)(DALS-GET Rating)的新股份。该公司收购了25,000股该公司股票,价值约为243,000美元。截至最近提交的美国证券交易委员会申请文件,Ursa Fund Management LLC持有DA32 Life Science Tech收购约0.10%的股份。
A number of other hedge funds also recently made changes to their positions in the business. Radcliffe Capital Management L.P. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at approximately $1,420,000. Saba Capital Management L.P. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at approximately $10,883,000. Fir Tree Capital Management LP acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter worth approximately $758,000. RP Investment Advisors LP lifted its holdings in DA32 Life Science Tech Acquisition by 653.1% during the 1st quarter. RP Investment Advisors LP now owns 408,856 shares of the company's stock worth $3,972,000 after purchasing an additional 354,569 shares during the last quarter. Finally, Verition Fund Management LLC acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter worth approximately $917,000. 60.43% of the stock is owned by institutional investors and hedge funds.
其他一些对冲基金最近也调整了它们在该业务中的头寸。Radcliffe Capital Management L.P.在第一季度收购了DA32生命科学技术公司收购的新股份,价值约1,420,000美元。萨巴资本管理公司在第一季度收购了DA32生命科学技术公司收购的新股份,价值约10,883,000美元。Fir Tree Capital Management LP在第一季度收购了DA32生命科学技术公司的新股份,价值约75.8万美元。RP Investment Advisors LP在第一季度增持了对DA32生命科学技术公司的收购,增持了653.1%。RP Investment Advisors LP现在拥有408,856股该公司的股票,价值3972,000美元,在上个季度又购买了354,569股。最后,Verition Fund Management LLC在第一季度收购了DA32生命科学技术公司的新股份,价值约917,000美元。60.43%的股票由机构投资者和对冲基金持有。
DA32 Life Science Tech Acquisition Price Performance
DA32生命科学技术收购价格表现
NASDAQ:DALS opened at $9.74 on Wednesday. The stock has a 50 day simple moving average of $9.72 and a 200 day simple moving average of $9.71. DA32 Life Science Tech Acquisition Corp. has a 1-year low of $9.58 and a 1-year high of $10.26.
纳斯达克:DALS周三开盘报9.74美元。该股的50日简单移动均线为9.72美元,200日简单移动均线为9.71美元。DA32生命科学技术收购公司的股价跌至9.58美元的一年低点和10.26美元的一年高点。
About DA32 Life Science Tech Acquisition
关于DA32生命科学技术收购
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.
DA32生命科学技术收购公司没有重大业务。它侧重于与一个或多个企业进行合并、资本换股、资产收购、股票购买、重组或相关业务合并。该公司打算确定生物技术和生命科学基础设施领域的业务合并目标。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
- Is Five Below Trying to Punch Too High?
- These 3 Reports Will Tell Us Much About the Current Economy
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 免费获取StockNews.com关于DA32生命科学技术收购(DALS)的研究报告
- 下面的五个是不是打得太高了?
- 这三份报告将告诉我们许多关于当前经济的情况。
- 这就是现在对标准普尔500指数的预期
- 关于甲骨文的FQ1报告,你需要知道的两件事
- 波动市场的三只价值股
Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating).
想看看其他对冲基金持有哪些DAL吗?访问HoldingsChannel.com获取DA32生命科学技术收购公司(纳斯达克代码:DALS-Get Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
获得DA32生命科学技术收购日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对DA32生命科学技术收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧